The following message is from Betsy Nugent, MSPH, CCRP, Chief Clinical Research Officer. This information applies to all studies interfaced from OnCore into Health Link with Active Billing. UW Health and the School of Medicine …
research
Weekly NIH funding opportunities and notices
New CounterACT R21 program Announcement
The Countermeasures Against Chemical Threats (CounterACT) team are happy to announce the new R21 Program Announcement with a first receipt date of May 30, 2018. PAR 18-721 (R21) – Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental …